Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Nathaniel13on Jan 25, 2021 10:59am
56 Views
Post# 32375092

Serology (Antibody) testing gaining momentum

Serology (Antibody) testing gaining momentumExperts say the true number of infections is probably much higher than the official tallies. Even with much more widespread testing now than in the pandemic’s early months, they say, many people who have never experienced symptoms may not have been tested or counted.

It would take a coordinated nationwide serology study program to move beyond modeling estimates and have a solid grasp of how many people have actually had the virus, he said. The CDC conducts some serology testing, he said, but not enough to provide a full picture.

“The bottom line is, we don’t know, but we can guess from modeling,” Longini said.

https://www.thenewstribune.com/news/nation-world/article248723630.html


 


Read more here: https://www.thenewstribune.com/news/nation-world/article248723630.html#storylink=cpy



Read more here: https://www.thenewstribune.com/news/nation-world/article248723630.html#storylink=cpy
<< Previous
Bullboard Posts
Next >>